Category Stocks

INmune Bio (INMB): Today’s Developments and Future Prospects

INmune Bio, Inc. (NASDAQ: INMB) is a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease. The company’s pipeline includes therapies targeting various diseases, including cancer and Alzheimer’s disease. Today, INmune Bio…

ON Semiconductor Corp (ON): A Comprehensive Update

ON Semiconductor Corp, a leading player in the semiconductor industry, announced its Q2 2024 earnings today, revealing significant insights into its current financial health and market position. The company reported earnings of $338.2 million for the quarter, translating to a…

Dexcom (DXCM) Faces a Tumultuous Day: Analysis and Predictions

Dexcom Inc. (NASDAQ: DXCM), a leading provider of continuous glucose monitoring (CGM) systems, experienced a significant stock price drop today following the release of its second-quarter 2024 earnings report. The company’s performance and forward guidance have raised concerns among investors…